Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins?

Journal of Diabetes Science and Technology

Volumn 5, Issue 1, 2011, Pages 136-149

  Lefkowitz, Mark ^a  

^a Lieberman Research Group   (United States)

Author keywords

Color differentiation; Insulin pen; Long acting insulin; Patient preference; Short acting insulin

Indexed keywords

INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; LONG ACTING INSULIN; SHORT ACTING INSULIN; ANTIDIABETIC AGENT; INSULIN;

ADULT; ARTICLE; COLOR; DIABETIC PATIENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT PREFERENCE; STRUCTURED INTERVIEW; TREATMENT OUTCOME; UNITED STATES; ADOLESCENT; APTITUDE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DIABETES MELLITUS; DRUG DOSAGE FORM; EQUIPMENT DESIGN; INSULIN INFUSION; JET INJECTION; LEARNING; MEDICATION ERROR; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT SATISFACTION; PHYSIOLOGY; PRODUCTIVITY; RANDOMIZED CONTROLLED TRIAL; TIME;

ADOLESCENT; ADULT; APTITUDE; ASSOCIATION LEARNING; COLOR; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS; DOSAGE FORMS; EFFICIENCY; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, JET; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEDICATION ERRORS; MIDDLE AGED; PATIENT SATISFACTION; TIME FACTORS; YOUNG ADULT;

EID: 79958011399     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500119     Document Type: Article

References (13)

1. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care. 2009;32(Suppl 1):S13-61.
2. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract. 1995;28(3):173-7.
3. D'Eliseo P, Blaauw J, Milicević Z, Wyatt J, Ignaut DA, Malone JK. Patient acceptability of a new 3.0 ml pre-filled insulin pen. Curr Med Res Opin. 2000;16(2):125-33.
4. Haak T, Edelman S, Walter C, Lecointre B, Spollett G. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, Lilly disposable pen, and a prototype pen: an open-label study. Clin Ther. 2007;29(4):650-60.
5. Korytkowski M, Bell D, Jacobsen C, Suwannasari R; FlexPen Study Team. A multicenter, randomized, open-label, comparative, twoperiod crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003;25(11):2836-48.
6. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther. 2004;26(9):1498-505.
7. Carter J, Roberts A. Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia. Curr Med Res Opin. 2008;24(10):2741-9.
8. Asakura T, Seino H, Nakano R, Muto T, Toraishi K, Sako Y, Kageyama M, Yohkoh N. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther. 2009;11(10):657-61.
9. Ignaut DA, Schwartz SL, Sarwat S, Murphy HL. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ. 2009;35(5):789-98.
10. Bode A. Development of the SoloSTAR insulin pen device: design verification and validation. Expert Opin Drug Deliv. 2009;6(1):103-12.
11. Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv. 2007;4(2):165-74.
12. Hirsch IB. Insulin packaging: a medical error waiting to happen. American Diabetes Society. DOCNEWS. 2006. Available from: http://docnews. diabetesjournals.org/content/3/5/7.full. Accessed May 2010.
13. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. 2008;126(12):1740-7.